We read with great interest the recent letter to Critical Care by Marik and Hooper [1] . Vitamin C (vit C) is increasingly recognized as a crucial compound to alleviate morbidity in critically ill patients. Vit C concentrations, however, are usually far below normal and even close to "scurvy levels" in this population. Vit C also is substantially cleared by continuous renal replacement therapy (CRRT). Significant vit C deficiency was observed in 80% of patients subjected to various types of CRRT despite receiving a daily intravenous (IV) supplement of 500 to 1000 mg [2] . Therefore, high-dose (from 6 to 12 g) vit C substitution during CRRT seems justified [3] .
Marik and Hooper argued against such dose increase in patients receiving CRRT. To support their statement, they provided serum vit C dosages in a small number of septic patients who received 6 g vit C IV while undergoing continuous veno-venous hemofiltration (CVVH). Vit C trough and peak levels were largely above normal and comparable to levels obtained in patients not receiving CVVH [1] .
We want to warn against oversimplification. Marik and Hooper measured vit C within 30 min after the end of vit C infusion. It would have been more relevant to measure vit C after 24 to 48 h of CVVH treatment. Up to 50% of vit C is cleared in a time-dependent manner during a 4-h session of intermittent hemodialysis or hemodiafiltration [4, 5] , which suggests that continuous techniques may exacerbate vit C losses. Vit C also is eliminated by both diffusion (dialysis) and convection (filtration). During hemodiafiltration, diffusion is responsible for two thirds of the vit C loss whereas convection accounts only for one third [5] . CVVH is a sheer convective technique in contrast with other oftenused CRRT modes in the critically ill, such as continuous veno-venous hemodialysis (CVVHD) and continuous veno-venous hemodiafiltration (CVVHDF). Marik and Hooper thus report the most modest way of CRRTinduced vit C elimination. It is reasonable to think that more diffusion-based CRRT techniques may yield other results.
We agree with Marik and Hooper that 6 g/day vit C IV is sufficient for patients without acute kidney injury and not requiring CRRT. However, vit C measurements should be performed after prolonged CVVH sessions to ensure that a 6 g daily supplement can keep levels within normal range. More studies are needed in patients receiving CVVHD or CVVHDF to exclude overlooking too great a vit C loss. 
